Application of N-oxidized tertiary amine containing polymer as medicine or carrier
A technology for oxidizing tertiary amine groups and polymers, applied in the field of medicine, can solve the problems of difficulty in entering cells to exert drug efficacy and weak interaction
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0092] Example 1: Synthesis of PODEAEMA-SN38 Bonds
[0093] The application of the N-oxidized tertiary amine-based polymer as a drug carrier in the present application, one embodiment of which includes bonding chemotherapeutic drugs. More specifically, in one embodiment, the loaded drug is 7-ethyl-10-hydroxycamptothecin (SN38), which is synthesized as follows.
[0094]
[0095] Where x=0.8~0.95, n=3~300
[0096] (1) Synthesis of PODEAEMA-NHS.
[0097] 2-(N,N-diethylamino)ethyl methacrylate (DEAEMA, 5.37g) and tert-butyl methacrylate (0.37g), 0.0041g ethyl 2-isobromobutyrate, 2,2 After putting 0.085 g of '-bipyridine, 0.038 g of cuprous bromide and 2 mL of methanol into the polymerization bottle, nitrogen gas was continuously fed for 30 minutes to remove oxygen. Then seal and react at 30°C for 6 hours. After the reaction is finished, the catalyst is removed through an aluminum oxide column, the obtained solution is concentrated and added to n-hexane for precipitation, an...
Embodiment 2
[0108] Embodiment 2: Preparation of PODEAEMA-b-polySN38 block copolymer
[0109] The application of the N-oxidized tertiary amine polymer as a drug carrier of the present application, one embodiment is to use the hydrophilic N-oxidized tertiary amine polymer as a long chain and connect it to the drug molecule or its polymer , to form amphiphilic bonded drugs that form nanoparticles or micelles through their assembly in aqueous solution. More specifically, in one embodiment, the loaded drug is 7-ethyl-10-hydroxycamptothecin (SN38), which is synthesized as follows.
[0110]
[0111] Wherein, m=3-200, n=3-300.
[0112] Add 240mg of 2-(N,N-diethylamino)ethyl methacrylate, 3.9mg of ethyl 2-isobromobutyrate, 40mg of pentamethyldiethylenetriamine, 10mg of cuprous bromide, and 1mL of DMF After entering the polymerization bottle, nitrogen gas was continuously passed through for 30 minutes to remove oxygen. Then seal and react at 40°C for 4 hours. Under the protection of argon, d...
Embodiment 3
[0115] An embodiment of the application of the N-oxide-based tertiary amine polymer as a macromolecular drug includes synthesizing the macromolecular drug itself as a macromolecular backbone structure. More specifically, in one embodiment, a nitrogen mustard polymer macromolecular drug of N-oxide polyethyleneimine (OPEI) (OPEI-Cl) is obtained.
[0116] Take 1.16 g of branched polyethyleneimine (Aldrich) with a weight average molecular weight of 25000 g / mol and dissolve it in 10 mL of formamide, and add 2.5 mL of propylene oxide in an ice-water bath. Stirring was continued overnight at 0°C, the resulting solution was dialyzed in water, and the dialysate was freeze-dried to obtain:
[0117]
[0118] Add 0.14g of the above product to 3mL of 30% hydrogen peroxide aqueous solution, stir at room temperature for 6 hours, then dialyze the water phase, and freeze-dry the dialyzate to obtain the N-oxidized product:
[0119]
[0120] Take 0.1 g of the above product, add 2 mL of fo...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com